首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Novel in situ liquefying antimicrobial wrap for preventing tissue expander infections following breast reconstructive surgeries
【24h】

Novel in situ liquefying antimicrobial wrap for preventing tissue expander infections following breast reconstructive surgeries

机译:新型原位液化抗菌包装材料,可防止乳房重建手术后组织扩张器感染

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Breast reconstruction surgeries using tissue expanders (TEs) have highly reported infection rates. To decrease this, we developed a method for disinfecting TEs and surgical pockets, where an antimicrobial solution was applied as a solid film at implantation that subsequently liquefied in situ to provide extended prophylaxis. Silicone discs cut from TEs were covered with gelatin-based films containing minocycline (M) and rifampin (R). Discs and films soaked in saline were subsequently challenged with pathogen at days 1, 3, 7, and 10 and quantified for potential biofilm formation. Discs that were not harvested at each specific time points were refreshed with sterile saline. The discs were challenged with clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), and multidrug-resistant Pseudomonas aeruginosa (MDR-PA). Recoveries of adherent organisms from uncovered silicone discs and gelatin-wrapped discs without added antimicrobial agents were >5 x 10(4) CFU/disc for each organism at each time point. Experimental 0.1%M/0.05%R gelatin films completely inhibited all challenge organisms from attaching to the silicone (p<0.05) at each time point through day 10. Cytotoxicity was assessed by incubating films with HEK-293T human fibroblasts. There were no significant differences in HEK-293T cell survival between controls and any of the antimicrobial films. The in situ liquefying, bioabsorable, antimicrobial wrap prevented biofilm formation by microorganisms on silicone surfaces in vitro with minimal cytotoxicity. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 369-374, 2016.
机译:使用组织扩张器(TEs)进行乳房再造手术的感染率很高。为了减少这种情况,我们开发了一种对TE和手术袋进行消毒的方法,其中在植入时将抗菌溶液作为固体膜施用,然后原位液化以提供延长的预防性。从TE切下的硅树脂圆片上覆盖有含有米诺环素(M)和利福平(R)的明胶基薄膜。随后在第1、3、7和10天用病原菌攻击浸泡在盐水中的光盘和胶片,并量化潜在的生物膜形成。在每个特定时间点未收获的圆盘用无菌盐水刷新。用耐甲氧西林的金黄色葡萄球菌(MRSA),耐甲氧西林的表皮葡萄球菌(MRSE)和耐多药的铜绿假单胞菌(MDR-PA)的临床分离菌对这些碟片进行攻击。对于每个生物体,在每个时间点从未发现的有机硅圆片和明胶包裹的圆片中未添加抗菌剂的附着生物的回收率均> 5 x 10(4)CFU / disc。实验性0.1%M / 0.05%R明胶薄膜在第10天的每个时间点完全抑制了所有挑战性生物附着到有机硅上(p <0.05),并通过将薄膜与HEK-293T人成纤维细胞一起孵育来评估细胞毒性。对照组和任何抗菌膜之间的HEK-293T细胞存活率均无显着差异。原位液化,可生物吸收的抗菌包裹物可在最小的细胞毒性下阻止微生物在体外在硅酮表面上形成生物膜。 (c)2015 Wiley Periodicals,Inc. J Biomed Mater Res B部分:Appl Biomater,104B:369-374,2016。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号